Search

Search Constraints

You searched for: Author/Creator Büscheck, Franziska

Search Results

1. 5q21 deletion is often heterogeneous in prostate cancer. Issue 8 (24th January 2019)

2. A shift from membranous and stromal syndecan‐1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer. Issue 12 (23rd September 2019)

3. Carboxypeptidase A1 (CPA1) Immunohistochemistry Is Highly Sensitive and Specific for Acinar Cell Carcinoma (ACC) of the Pancreas. (January 2022)

4. Chromosome 5 harbors two independent deletion hotspots at 5q13 and 5q21 that characterize biologically different subsets of aggressive prostate cancer. Issue 3 (24th October 2020)

5. Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10, 439 tumors. Issue 2 (7th November 2022)

6. Diagnostic and Prognostic Impact of Progesterone Receptor Immunohistochemistry: A Study Evaluating More Than 16, 000 Tumors. (8th August 2022)

7. Expression of CCCTC‐binding factor (CTCF) is linked to poor prognosis in prostate cancer. Issue 1 (29th November 2019)

8. High B7‐H3 expression is linked to increased risk of prostate cancer progression. Issue 10 (10th August 2020)

9. High density of cytotoxic T-lymphocytes is linked to tumoral PD-L1 expression regardless of the mismatch repair status in colorectal cancer. (2nd September 2021)

10. High RSF1 protein expression is an independent prognostic feature in prostate cancer. (3rd March 2020)